Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?

Geisler C, Kolstad A, Laurell A, Räty R, Nordic Lymphoma Group, Mantle Cell Lymphoma Subcommittee.

Open source

DOI
10.1080/10428190903040030
Published
2009-08-01
Container
Leuk Lymphoma
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/10428190903040030,
  title = {Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?},
  author = {Geisler C and  Kolstad A and  Laurell A and  Räty R and  Nordic Lymphoma Group and  Mantle Cell Lymphoma Subcommittee.},
  year = {2009},
  journal = {Leuk Lymphoma},
  doi = {10.1080/10428190903040030},
  url = {https://doi.org/10.1080/10428190903040030}
}

RIS

TY  - JOUR
TI  - Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?
AU  - Geisler C
AU  -  Kolstad A
AU  -  Laurell A
AU  -  Räty R
AU  -  Nordic Lymphoma Group
AU  -  Mantle Cell Lymphoma Subcommittee.
PY  - 2009
JO  - Leuk Lymphoma
DO  - 10.1080/10428190903040030
UR  - https://doi.org/10.1080/10428190903040030
ER  - 

APA

C, G., A, K., A, L., R, R., Group, N. L., & Subcommittee., M. C. L. (2009). Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?. Leuk Lymphoma. https://doi.org/10.1080/10428190903040030

Source records